Related references
Note: Only part of the references are listed.Control Mechanisms of the Tumor Suppressor PDCD4: Expression and Functions
Sachiko Matsuhashi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Detection of Novel NRG1, EGFR, and MET Fusions in Lung Adenocarcinomas in the Chinese Population
Yunjian Pan et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
The role of Pdcd4 in tumour suppression and protein translation
Qing Wang et al.
BIOLOGY OF THE CELL (2018)
Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers
Alexander Drilon et al.
CANCER DISCOVERY (2018)
NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
Christoph Heining et al.
CANCER DISCOVERY (2018)
Comprehensive Characterization of Cancer Driver Genes and Mutations (vol 173, 371.e1, 2018)
Matthew H. Bailey et al.
CELL (2018)
HER kinase inhibition in patients with HER2-and HER3-mutant cancers
David M. Hyman et al.
NATURE (2018)
A Case of Invasive Mucinous Pulmonary Adenocarcinoma with a CD74-NRG1 Fusion Protein Targeted with Afatinib
Parneet K. Cheema et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Regulation of the prometastatic neuregulin-MMP13 axis by SRC family kinases: therapeutic implications
Ana Orive-Ramos et al.
MOLECULAR ONCOLOGY (2017)
Successful targeting of the NRG1 pathway indicates novel treatment strategy for metastatic cancer
M. R. Jones et al.
ANNALS OF ONCOLOGY (2017)
Breast cancer dissemination promoted by a neuregulin-collagenase 3 signalling node
S. Seoane et al.
ONCOGENE (2016)
Oncogenic Fusion Gene CD74-NRG1 Confers Cancer Stem Cell-like Properties in Lung Cancer through a IGF2 Autocrine/Paracrine Circuit
Takahiko Murayama et al.
CANCER RESEARCH (2016)
Targeting the EGF/HER Ligand-Receptor System in Cancer
Azucena Esparis-Ogando et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Neuregulin expression in solid tumors: Prognostic value and predictive role to anti-HER3 therapies
Alberto Ocana et al.
ONCOTARGET (2016)
RSK-mediated down-regulation of PDCD4 is required for proliferation, survival, and migration in a model of triple-negative breast cancer
Rafael Cuesta et al.
ONCOTARGET (2016)
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics
Carlos L. Arteaga et al.
CANCER CELL (2014)
Control of a tumor suppressor PDCD4: Degradation mechanisms of the protein in hepatocellular carcinoma cells
Sachiko Matsuhashi et al.
CELLULAR SIGNALLING (2014)
Phosphoproteomic analysis identifies the tumor suppressor PDCD4 as a RSK substrate negatively regulated by 14-3-3
Jacob A. Galan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
CD74-NRG1 Fusions in Lung Adenocarcinoma
Lynnette Fernandez-Cuesta et al.
CANCER DISCOVERY (2014)
Phosphorylation of P-Rex1 at serine 1169 participates in IGF-1R signaling in breast cancer cells
Juan Carlos Montero et al.
CELLULAR SIGNALLING (2013)
Molecular Pathways: P-Rex in Cancer
Atanasio Pandiella et al.
CLINICAL CANCER RESEARCH (2013)
Down-regulation of programmed cell death 4 leads to epithelial to mesenchymal transition and promotes metastasis in mice
Qing Wang et al.
EUROPEAN JOURNAL OF CANCER (2013)
P-Rex1 participates in Neuregulin-ErbB signal transduction and its expression correlates with patient outcome in breast cancer
J. C. Montero et al.
ONCOGENE (2011)
Structure of the Human mTOR Complex I and Its Implications for Rapamycin Inhibition
Calvin K. Yip et al.
MOLECULAR CELL (2010)
The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation
Brigitte Lankat-Buttgereit et al.
BIOLOGY OF THE CELL (2009)
ErbB receptors and signaling pathways in cancer
Nancy E. Hynes et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
ErbB receptors and the development of the nervous system
Carmen Birchmeier
EXPERIMENTAL CELL RESEARCH (2009)
Neuregulin expression modulates clinical response to trastuzumab in patients with metastatic breast cancer
Enrique de Alava et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The extracellular linker of pro-neuregulin-α2c is required for efficient sorting and juxtacrine function
Juan C. Montero et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
S6K1- and βTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth
N. Valerio Dorrello et al.
SCIENCE (2006)
Akt phosphorylates and regulates Pdcd4 tumor suppressor protein
A Palamarchuk et al.
CANCER RESEARCH (2005)
Bortezomib is an efficient agent in plasma cell leukemias
A Esparís-Ogando et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA
M Böhm et al.
ONCOGENE (2003)
Mitogen-activated protein kinase-dependent and -independent routes control shedding of transmembrane growth factors through multiple secretases
JC Montero et al.
BIOCHEMICAL JOURNAL (2002)
Differential shedding of transmembrane neuregulin isoforms by the tumor necrosis factor-α-converting enzyme
JC Montero et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2000)
Share Paper
